The PBM is pivoting to a cost-based reimbursement model, which it says will reduce variation in how pharmacies are paid.

Optum Rx is shifting its payment models to better meet the needs of pharmacies and consumers, the pharmacy benefit manager ...

The massive pharmacy benefit manager plans to stop requiring coverage reauthorizations for roughly 80 drugs used to treat ...

The PBM plans to stop requiring coverage reauthorization for about 80 drugs, including Vertex’s cystic fibrosis medicines and ...

Optum Rx's new cost-based program uses an internal algorithm that leverages multiple available industry data sources, such as ...

Third-party companies known as pharmacy benefit managers, which administer prescription drug benefits for health insurance ...

UNH and EPN join forces to enhance pharmacy reimbursement, ensuring fair payments and better stability for independent pharmacies.

Optum Rx will align payment models more closely to the costs pharmacies may face due to manufacturing pricing actions effective immediately and with full implementation by January ...

Optum Rx has eliminated prior authorization for almost 70 drugs for chronic diseases, about 10% of its overall pharmacy prior ...

Optum Rx announced on Wednesday that it will eliminate up to 25% of reauthorizations, initially focusing on 80 drugs. | Optum ...

Optum Rx is cutting prior authorizations on 80 drugs and updating payment models to improve reimbursements, benefiting ...

Rising prices set by pharmaceutical companies are causing pharmacies across the United States to pay more for many drugs, impacting their ability to maintain high-quality care for patients.